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Introduction 
Histoplasmosis (HP) is a systemic mycosis caused by 
the dimorphic fungus Histoplasma capsulatum, 
which has two variants: Histoplasma capsulatum var. 
capsulatum, prevalent in the Americas, and 
Histoplasma capsulatum var. dubuosii, most common 
in regions of Africa [1, 2]. Environmental sources of H. 
capsulatum include bat, chickens and birds, soil, and 
other organic substrates [3, 4]. The recognition of the 
worldwide presence of Histoplasma capsulatum has 
been modifying the epidemiology of systemic 
mycoses in the Americas, where for many years 
paracoccidioidomycosis was considered the most 
prevalent [3]. 
Histoplasmosis is widely distributed in the Americas 
and is very prevalent in certain areas of the United 
States, Mexico, Panama, the Caribbean, and several 
South American countries, including Brazil [4]. 
Northern Brazilian states, such as Amazonas, are 
considered endemic for histoplasmosis [5]. 
Fungal diseases kill more than 1.5 million people and 
affect more than 1 billion, but they are still neglected 
by the world's health authorities, including Brazilian 
authorities [6, 7]. Only last year, systemic mycoses 
were included in the group of tropical neglected 
diseases of the World Health Organization [8]. Recent 
global estimates have found more than 100,000 
cases of disseminated histoplasmosis, a serious 
fungal infection that occurs as a consequence of 
certain health problems, such as HIV-AIDS [6]. 
As a consequence of the HIV-AIDS pandemic, 
disseminated histoplasmosis has become prevalent 
not only in regions that are recognized as endemic, 
but also in areas not considered endemic [9], such as 
Abstract 
Histoplasmosis is a systemic mycosis caused by the 
dimorphic fungus Histoplasma capsulatum, with 
disseminated histoplasmosis (HD) being one of its 
clinical forms. As a consequence of the HIV-AIDS 
pandemic, HD has become prevalent not only in 
regions that are recognized as endemic but also in 
areas not considered endemic, such as Europe and 
Asia. Its clinical manifestations are varied and mimic 
several infectious diseases, mainly tuberculosis. In 
endemic areas, it is the first manifestation of AIDS in 
50 to 70% of patients. The diagnosis of 
histoplasmosis is difficult and HD can lead to death if 
not diagnosed early and if proper treatment is not 
instituted. The present report presents a patient with 
a recent diagnosis of HIV-AIDS, in treatment for 
miliary tuberculosis, who was diagnosed with 
disseminated histoplasmosis because of his 
dermatological manifestations. 
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Europe and Asia [5]. Its clinical manifestations are so 
varied that this systemic mycosis is referred to as 
syphilis of the fungal world or the great imitator, 
because the disease mimics several non-infectious 
and infectious diseases, especially tuberculosis [3]. 
Underdiagnosis usually occurs owing to the relative 
lack of specific laboratory and radiological tests [7]. 
In endemic areas, such as Latin America, it is the first 
manifestation of AIDS in 50 to 70% of patients [10] 
and may lead to death if it is not recognized early and 
treated [3]. 
The present report is the case of a patient with a 
recent diagnosis of retrovirosis, already in treatment 
for miliary tuberculosis, who was diagnosed with 
disseminated histoplasmosis during his 
hospitalization through dermatological 
manifestations.  
 
Case Synopsis 
A 22-year-old man was transferred, to Manaus in 
December 2017 because of co-infection of HIV and 
miliary tuberculosis (TBM). At admission, the patient 
reported asthenia and weight loss of 10kg for two 
months. He noted worsening dyspnea, productive 
cough of whitish discharge, intermittent fever, 
odynophagia, and xerostomia in the last month. 
On physical examination, the patient was emaciated 
and dehydrated and exhibited, whitish plaques in 
the oral cavity suggestive of moniliasis. Pulmonary 
auscultation revealed murmur and diffuse wheezing 
and crepitations. Hepatosplenomegaly was found 
on abdominal palpation. Antiretroviral therapy (ART) 
was instituted with tenofovir 300mg, lamivudine 
300mg (2-in-1), and raltegravir 400mg orally. In 
addition he was given treatment for oral moniliasis 
and continued treatment of tuberculosis with the 
regimen rifampicin 150mg, isoniazid 75mg, 
pyrazinamide 400mg, and ethambutol 275mg 
(COXIP) orally.  
Laboratory tests collected at the patient's admission 
showed pancytopenia (erythrocytes 3.16 
million/mm3  (reference value [RV] 4.2-5.5 
million/mm3), hemoglobin 9.38 g/dl (RV 12.5-15.5 
g/dl ), hematocrit 27.97% (RV 36-47%), leukocytes 
3.290/mm3 (RV 4.000-10.000/mm3, lymphocytes 14% 
(RV 25-40%), platelets 44.000/mm3 (RV 150.000-
450.000/mm3)), hypoalbuminemia 2.9 (RV 3.5-4.5g/dl 
), hyperbilirubinemia (total bilirubin 2.46mg/dl (RV 
0.01-1.3 mg/dl), direct bilirubin 1.2mg/dl (RV 0.01-
0.3mg/dl), indirect bilirubin 1.26mg/dl (RV 0.01-
0.7mg/dl)). 
The CD4 count on the third day of hospitalization 
was 37 cells/μl (17.14%), CD8 135 cells/μl (61.89%), 
viral load 3,000,000 copies and reticulocyte count 
15.0% (RV 0.56-2.72%).  
Chest X-ray on admission showed diffuse 
micronodular infiltrate in both lungs. Computed 
tomography of the chest showed diffuse reticular 
opacities in both hemithorax, tending to 
consolidation in lower lobes, and a small bilateral 
pleural effusion.  
Patient progressed with intermittent abdominal 
pain, bloody diarrhea, vomiting, genital ulcers, 
inguinal lymphadenopathy, and left visual field 
dimming. There were persistent respiratory 
complaints, odynophagia, fever, and pancytopenia. 
After 18 days of hospitalization, the patient 
developed an erythematous-violet nodule, with 
ulcer and crust in the center, located in the right 
malar region. In addition, erythematous papules with 
A B 
  
 
Figure 1. A) Erythematous-violet nodule, infiltrated aspect, with 
central ulceration located in the right malar region. B) 
Erythematous-violet papules, with infiltrated base, containing 
central ulceration topped by hematic crostulas, located in the left 
malar region, with mollusc-like characteristics. There are also 
small papules and ulcerations in the left nasal region. 
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central crusts were distributed in the left malar 
region (Figure 1). In view of the above, the 
differential diagnosis included disseminated 
histoplasmosis, disseminated cryptococcosis, and 
paracoccidioidomycosis. 
A biopsy of the cutaneous lesions was performed on 
the nineteenth day of hospitalization. 
Histopathological analysis revealed granulomatous 
inflammatory infiltrate consisting of lymphocytes, 
epithelioid cells, and small structures inside and 
outside histiocytes in the dermis [11], (Figure 2). 
Special staining by the Grocott method [11] 
demonstrated immune fungal structures (Figure 3), 
confirming the hypothesis of disseminated 
histoplasmosis. Intravenous amphotericin B therapy 
was instituted at a dose of 50mg per day for 14 days. 
After the end of this period, the patient started 
itraconazole 100mg orally, with a dose of 200mg per 
day. The patient was discharged on the thirty-fourth 
day of hospitalization on ART, COXIP, and 
itraconazole with clinical and laboratory 
improvement.  
 
Case Discussion 
Histoplasmosis caused by Histoplasma capsulatum 
var. capsulatum typically presents as an acute or 
febrile respiratory condition, but the literature states 
that the manifestations vary according to the 
individual's immune status and the number of 
inhaled fungal particles [2]. Epidemics of acute 
histoplasmosis have occurred in endemic and non-
A 
Figure 3. Histopathological slide with special staining by the 
Grocott method (40×, arrows point to pathogens), evidencing 
immune fungal structures inside and outside histiocytes in the 
dermis. 
 
 
Figure 2. A) Histopathological slide stained by hematoxylin and eosin (40×), showing skin fragment containing dense and diffuse 
inflammatory infiltrate involving superficial and deep dermis composed of lymphocytes, epithelioid cells and small structures inside and 
outside histiocytes in the dermis. B) Histopathological lamina stained with hematoxylin and eosin (400×), showing skin fragment with 
central epithelioid cell and small structures inside and outside histiocytes in the dermis (arrows). 
A	 B
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endemic areas after exposure to environments 
contaminated with fungus, particularly caves and 
other environments inhabited by bats or fowl, [4]. 
After being questioned, the patient reported having 
a fowl run in his residence and noted prolonged 
contact with the chickens. 
Clinically, there are three forms: acute pulmonary, 
chronic, and disseminated pulmonary 
histoplasmosis (HD), the last appearing in 95% of 
HIV-positive patients who are at higher risk when the 
CD4 The lymphocyte count is <50 cells/μl [15]. The 
involvement of HIV-negative individuals is rare [14]. 
The patient's cell count in this report was 37 cells/μl 
with a viral load of 3,000,000 copies. 
Studies indicate that the main symptoms of 
disseminated histoplasmosis include fever, general 
malaise, weight loss, cough, anorexia, diarrhea, and 
intermittent abdominal pain. Physical examination 
often shows hepatosplenomegaly, 
lymphadenopathy, pallor, and petechiae if 
pancytopenia is present. The involvement of 
pulmonary, ocular, gastrointestinal, and 
genitourinary tracts observed in the patient's clinical 
history is already described in the literature. Other 
systems often involved include cardiac, 
osteoarticular, and central nervous system in 
patients with HD [13, 16, 17]. Brazilian research that 
analyzed clinical and epidemiological characteristics 
of HIV-positive patients with disseminated 
histoplasmosis at the hospital of infectious diseases 
in the state of Goiânia showed that the most 
common affected organ was the lung, followed by 
liver, and cutaneous involvement [7]. 
Cutaneous lesions of histoplasmosis occur in less 
than 10% of patients in the USA, but are present in 
38 to 85% of the cases reported in Latin America [12]. 
In Brazil, cutaneous lesions as the first clinical 
manifestation of opportunistic diseases in patients 
living with HIV are not uncommon and in the case of 
histoplasmosis, they are particularly evident [18]. 
They vary from macular, violaceous, papular, 
sometimes acneiform or mimicking contagious 
molluscum, plaques, and ulcerations, which may 
appear isolated or associated [15]. The discrete 
dermatological manifestations described in the 
literature are in agreement with lesions in our 
patient. 
There are no laboratory-specific changes in the 
disease, and suggestive alterations include 
pancytopenia, elevated liver enzymes, elevated 
Westergren sedimentation rate, elevated C-reactive 
protein, and increased serum ferritin [4, 13]. Chest 
imaging examinations, such as radiography and 
computed tomography, may reveal normality [3] or 
diffuse pulmonary infiltrates [16]. Interstitial [4] or 
miliary patterns that are seen in patients with 
tuberculosis [19]. In the present report, a miliary 
pattern was observed. 
The diagnosis of HIV-associated histoplasmosis is 
confounded with tuberculosis [9] because of the 
similarity of symptoms and changes in imaging tests 
[2]. In cases of HIV-positive patients who do not 
respond well to therapy against tuberculosis, co-
infection with histoplasmosis should be considered 
[19]. It is worth noting that, in the present case, 
therapy for miliary tuberculosis was not 
discontinued. 
The diagnosis of histoplasmosis is often difficult. A 
careful clinical history of possible exposure to H. 
capsulatum in daily activities or during a recent trip is 
crucial to arrive at the correct diagnosis [13]. Biopsy 
of skin [4], gastrointestinal tract, or aspirate of the 
bone marrow are necessary to obtain tissues or fluids 
for culture and histopathology [3]. In the 
histopathological analysis of material collected 
through skin biopsy, we observed the presence of 
sarcoid-like epithelioid granulomas, with 
microorganisms inside the phagocytic cells. Special 
stains, such as Gomori-Grocott and periodic acid 
Schiff, are required for proper visualization of the 
fungus. Cultures are very useful for diagnosis in 
individuals with the disseminated form, but they 
rarely show positivity in the acute forms, delaying 
the start of treatment [4]. 
The detection of antibodies may be useful but is not 
as sensitive, since false positives may occur [3, 9]. 
Histoplasma capsulatum antigen can be detected in 
many patients with HD, allowing the early diagnosis 
of the disease. However, in endemic countries, 
access to this diagnostic test is restricted [3]. The 
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literature indicates that the sensitivity of the 
diagnostic methods for disseminated histoplasmosis 
is 76% for histopathology, 74% culture, 75% 
antibodies, and 92% antigens [3]. 
In patients with AIDS, disseminated histoplasmosis 
shows signs and symptoms commonly seen in other 
diseases that affect these individuals, such as miliary 
tuberculosis, disseminated cryptococcosis, 
paracoccidioidomycosis, and lymphomas with 
extensive intra-abdominal involvement [4]. 
For treatment of disseminated histoplasmosis in HIV-
positive patients, liposomal amphotericin B at the 
dose of 3mg/kg/day is the drug of choice. If not 
available, amphotericin B deoxycholate should be 
used at a dose of 1mg/kg/day. Both should be 
followed by itraconazole for at least one year [3]. A 
study looking at eradication of these fungi from HIV-
positive patients diagnosed with disseminated 
histoplasmosis compared liposomal amphotericin B 
versus intraconazole and showed that faster 
elimination of fungemia occurred in patients who  
were given liposomal amphotericin B than those 
who were administered itraconazole for moderate 
and severe forms of histoplasmosis [20]. In Brazil, 
access to liposomal amphotericin B is restricted to 
the public health system owing to its high cost. Often 
then, initial treatment is with amphotericin B 
deoxycholate for 2 weeks followed by itraconazole. 
 
Conclusion 
The present case shows the importance of the 
recognition of skin lesions by health professionals as 
indicators of histoplasmosis, a serious and 
potentially fatal systemic disease, allowing the early 
diagnosis and treatment. In addition, global health 
authorities should pay special attention to 
histoplasmosis and develop public policies for the 
prevention and control of this disease. 
 
Potential conflicts of interest 
The authors declare no conflicts of interests. 
 
 
References 
1. Gonzalez Tv, Dinato SLMe, Sementilli A, et. al. Atypical 
presentation of histoplasmosis in an immunocompromised 
patient. An Bras Dermatol. 2015;90:32-5.[PMID: 26312668]. 
2. Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. 
Histoplasmosis in Africa: An emerging or a neglected disease? 
PLoS Negl Trop Dis. 2018;12:e0006046. [PMID: 29346384]. 
3. Queiroz-Telles F, Fahal AH, Falci DR, et al. Neglected endemic 
mycoses. Lancet Infect Dis. 2017;17:e367-e77. [PMID: 28774696]. 
4. Ferreira MS, Borges AS. Histoplasmose. Rev Soc Bras Med Trop. 
2009;42:192-8.[PMID: 19448941]. 
5. Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections 
worldwide: thinking outside of the Ohio River valley. Curr Trop 
Med Rep. 2015;2:70-80. [PMID: 26279969]. 
6. Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-
National Prevalence of Fungal Diseases-Estimate Precision. J Fungi 
(Basel). 2017;3. [PMID: 29371573]. 
7. da Silva Ferreira B, de Araujo Filho JA, Matos Pereira N, et al. 
Disseminated histoplasmosis in AIDS patients: an urban disease. 
Experience in a metropolis in the middle east of Brasil. Infez Med. 
2017;25:258-62. [PMID: 28956543]. 
8. WHO. Neglected tropical diseases. World Health Organization. 
2018. http://www.who.int/neglected_diseases/diseases/en/. 
Accessed on February 3, 2018. 
9. Dantas KC, Freitas RS, da Silva MV, et al. Comparison of diagnostic 
methods to detect Histoplasma capsulatum in serum and blood 
samples from AIDS patients. PloS one. 2018;13:e0190408. [PMID: 
29342162]. 
10. Dantas KC, Freitas RS, Moreira APV, et al. The use of nested 
Polymerase Chain Reaction (nested PCR) for the early diagnosis of 
Histoplasma capsulatum infection in serum and whole blood of 
HIV-positive patients. An Bras Dermatol. 2013;88:141-3.[PMID: 
23539023]. 
11. Kradin RL. Diagnostic Phathology of Infectious Disease. Schmitt 
W, DeFranccesco K, editors. 1st ed. Elsevier Inc; 2010. p. 570-71. 
12. Vidyanath S, Shameena P, Sudha S, Nair RG. Disseminated 
histoplasmosis with oral and cutaneous manifestations. J Oral 
Maxillofac Pathol. 2013;17:139-42. [PMID: 23798850]. 
13. Kauffman CA. Histoplasmosis: a clinical and laboratory update. 
Clin Microbiol Rev. 2007;20:115-32. [PMID: 17223625]. 
14. Ferreira OG, Cardoso SV, Borges AS, Ferreira MS, Loyola AM. Oral 
histoplasmosis in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod. 2002;93:654-9. [PMID: 12142871]. 
15. Orsi AT, Nogueira L, Chrusciak-Talhari A, et al. Coinfecção 
histoplasmose e Aids. An Bras Dermatol. 2011;86:1025-6.[PMID: 
22147050]. 
16. McKinsey DS, McKinsey JP. Pulmonary histoplasmosis. Semin 
Respir Crit Care Med. 2011;32:735-44. [PMID: 22167401]. 
17. Diaz RI, Sigler EJ, Rafieetary MR, Calzada JI. Ocular histoplasmosis 
syndrome. Surv Ophthalmol. 2015;60:279-95. [PMID: 25841248]. 
18. Marques SA, Silvares MRC, Camargo RMPd, Marques MEA. 
Cutaneous histoplasmosis disclosing an HIV-infection. An Bras 
Dermatol. 2013;88:420-3.[PMID: 23793220]. 
19. Evrard S, Caprasse P, Gavage P, et al. Disseminated histoplasmosis: 
case report and review of the literature. Acta Clin Belg. 2017:1-8. [ 
PMID: 28954600]. 
20. Wheat LJ, Cloud G, Johnson PC, et al. Clearance of fungal burden 
during treatment of disseminated histoplasmosis with liposomal 
amphotericin B versus itraconazole. Antimicrob Agents Chemother. 
2001;45:2354-7. [PMID: 11451696]. 
Volume 25 Number 8| August 2019| 
25(8):7 
 
 
- 6 - 
Dermatology Online Journal  ||  Case Presentation
 
